Runda Medical to forgo early redemption of convertible bonds

Shanghai Runda Medical Technology announced its A-share stock met the conditions for early redemption of the "Runda convertible bond" between August 25, 2025, and September 17, 2025. During this period, the closing price was not less than 130% of the current conversion price for at least fifteen trading days within thirty consecutive trading days. However, the company's fifth board meeting on September 17, 2025, unanimously resolved not to exercise the early redemption right.

This decision was made after considering existing capital allocation plans and current market conditions to safeguard investor interests. The board also stipulated that if the redemption trigger conditions are met again within the next three months (September 18, 2025, to December 17, 2025), the company will similarly not exercise its early redemption right. Following December 17, 2025, any future trigger will prompt a new board meeting to decide on exercising the right.

The "Runda convertible bond," with a total issuance of 550 million yuan, began trading on July 13, 2020, with an initial conversion price of 13.36 yuan per share. The conversion price has been adjusted multiple times, most recently to 12.97 yuan per share effective July 18, 2025. Sinolink Securities verified the decision, finding it to comply with relevant regulations.